Inogent Laboratories Profile
Key Indicators
- Authorised Capital ₹ 45.00 Cr
as on 27-04-2024
- Paid Up Capital ₹ 16.13 Cr
as on 27-04-2024
- Company Age 19 Year, 6 Months
- Last Filing with ROC 31 Mar 2017
- Satisfied Charges ₹ 105.00 Cr
as on 27-04-2024
- Revenue 26.07%
(FY 2016)
- Profit 255.72%
(FY 2016)
- Ebitda 75.71%
(FY 2016)
- Net Worth 29.07%
(FY 2016)
- Total Assets 26.95%
(FY 2016)
About Inogent Laboratories
- CIN/LLPIN
U24239TG2005PTC046402
- Company No.
046402
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
01 Jun 2005
- Date of AGM
17 Jul 2017
- Date of Balance Sheet
31 Mar 2017
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Inogent Laboratories Private Limited offer?
Inogent Laboratories Private Limited offers a wide range of products and services, including Product Development Research, Custom Research Service, Third Party Manufacturing Consultancy, Contract Manufacturing Services, Laboratory Apparatus, Chemistry Lab Apparatus, Business Planning and Management, Business Consultant.
Who are the key members and board of directors at Inogent Laboratories?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Subhash Nalajala | Company Secretary | Current |
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Venkata Gunupati  | Director | 01-Jun-2005 | Current |
| Venkata Gunupati | Director | 01-Jun-2005 | Current |
| Davinder Brar | Director | 30-Sep-2005 | Current |
| Manmahesh Kantipudi | Director | 14-Mar-2016 | Current |
Financial Performance and Corporate Structure Insights of Inogent Laboratories.
Inogent Laboratories Private Limited, for the financial year ended 2016, experienced significant growth in revenue, with a 26.07% increase. The company also saw a substantial improvement in profitability, with a 255.72% increase in profit. The company's net worth Soared by an impressive increase of 29.07%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Inogent Laboratories?
In 2017, Inogent Laboratories had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Novopan Industries Private LimitedActive 40 years 3 monthsVenkata Gunupati and Venkata Gunupati are mutual person
- Gvk Natural Resources Private LimitedActive 13 years 10 months
Venkata Gunupati and Venkata Gunupati are mutual person
- Gvk Properties And Management Company Private LimitedActive 24 years 11 months
Venkata Gunupati is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 17 Jun 2016 | ₹85.00 Cr | Satisfied |
Canara Bank Creation Date: 03 Mar 2010 | ₹20.00 Cr | Satisfied |
How Many Employees Work at Inogent Laboratories?
Unlock and access historical data on people associated with Inogent Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Inogent Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Inogent Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
